financetom
Business
financetom
/
Business
/
YETI's Valuation Remains 'Compelling;' Potential Upside Likely in H2, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
YETI's Valuation Remains 'Compelling;' Potential Upside Likely in H2, BofA Says
Aug 9, 2024 8:54 AM

11:41 AM EDT, 08/09/2024 (MT Newswires) -- YETI Holdings' ( YETI ) valuation remains "compelling" compared with other leisure brands, with the company expected to see a potential upside in H2 and long-term support from international growth, BofA Securities said in a note emailed Friday.

The firm raised its 2024 earnings estimate for YETI to $2.65 per share from $2.60 after the company reported Q2 EPS of $0.70, versus BofA's estimate of $0.63.

Multiple factors are expected to drive YETI's growth in H2, including the NFL licensing deal for drinkware and coolers, strong sales during Amazon Prime Day in Q3 and the contribution of new products, BofA said.

The company's plans to extend its presence in the international markets, diversify product offerings to include cookware and backpacks, and additional mergers and acquisitions to acquire technology, design, and talent will support its long-term growth, BofA added.

BofA said it upgraded its rating on YETI's stock to buy from neutral on anticipated continued momentum driven by new product categories and international expansion. It also raised its price target to $55 from $46.

Price: 41.21, Change: -1.91, Percent Change: -4.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bayer wins victory in US legal battle against Roundup cancer claims
Bayer wins victory in US legal battle against Roundup cancer claims
Aug 15, 2024
(Reuters) - Bayer won a legal victory in its fight to limit liability from claims that its Roundup weed killer causes cancer, as a U.S. appeals court on Thursday said federal law shields the German company from a lawsuit by a Pennsylvania landscaper. The 3rd U.S. Circuit Court of Appeals in Philadelphia rejected plaintiff David Schaffner's claim that Bayer's Monsanto...
Peyto Exploration To Pay $0.11 Monthly Dividend
Peyto Exploration To Pay $0.11 Monthly Dividend
Aug 15, 2024
05:10 PM EDT, 08/15/2024 (MT Newswires) -- Peyto Exploration & Development ( PEYUF ) on Thursday confirmed a monthly dividend for August of $0.11 per share paid on Sept. 13 to shareholders of record on Aug. 31. This is consistent with last month's dividend of $0.11. ...
BRIEF-Kroger Says After Merger Closes, Will Invest $1 Bln To Lower Albertsons' Prices
BRIEF-Kroger Says After Merger Closes, Will Invest $1 Bln To Lower Albertsons' Prices
Aug 15, 2024
Aug 15 (Reuters) - Kroger Co ( KR ): * KROGER ( KR )- AFTER ALBERTSONS MERGER CLOSES, KROGER WILL INVEST $1 BILLION TO LOWER ALBERTSONS' PRICES Source text for Eikon: Further company coverage: ...
Keros Therapeutics Insider Sold Shares Worth $11,002,500, According to a Recent SEC Filing
Keros Therapeutics Insider Sold Shares Worth $11,002,500, According to a Recent SEC Filing
Aug 15, 2024
05:12 PM EDT, 08/15/2024 (MT Newswires) -- Carl L Gordon, Director, on August 13, 2024, sold 250,000 shares in Keros Therapeutics ( KROS ) for $11,002,500. Following the Form 4 filing with the SEC, Gordon has control over a total of 119,522 shares of the company, with 119,522 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1664710/000094787124000703/xslF345X03/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved